Tianshui Zhongxing Bio-technology Co.,Ltd.
Symbol: 002772.SZ
SHZ
7.08
CNYMarkedspris i dag
-764.5012
P/E-forhold
44.3411
PEG Ratio
2.78B
MRK Cap
- 0.00%
DIV Udbytte
Tianshui Zhongxing Bio-technology Co.,Ltd. (002772-SZ) Årsregnskaber
Balance
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 0 | 1323.5 | 1695.7 | 1858.6 | |||||||||||||
balance-sheet.row.short-term-investments | 0 | 285 | 369.5 | 263.4 | |||||||||||||
balance-sheet.row.net-receivables | 0 | 28.3 | 80.9 | 21.6 | |||||||||||||
balance-sheet.row.inventory | 0 | 1274.6 | 1255.5 | 1173.9 | |||||||||||||
balance-sheet.row.other-current-assets | 0 | 32.8 | 4.8 | 24.4 | |||||||||||||
balance-sheet.row.total-current-assets | 0 | 2659.2 | 3036.9 | 3078.5 | |||||||||||||
balance-sheet.row.property-plant-equipment-net | 0 | 2946.8 | 3074 | 3005.4 | |||||||||||||
balance-sheet.row.goodwill | 0 | 0 | 0 | 0 | |||||||||||||
balance-sheet.row.intangible-assets | 0 | 334.4 | 342.4 | 350.6 | |||||||||||||
balance-sheet.row.goodwill-and-intangible-assets | 0 | 334.4 | 342.4 | 350.6 | |||||||||||||
balance-sheet.row.long-term-investments | 0 | 123.7 | -285.2 | -170.9 | |||||||||||||
balance-sheet.row.tax-assets | 0 | 0 | 0 | 268.3 | |||||||||||||
balance-sheet.row.other-non-current-assets | 0 | 9.7 | 401.1 | 19.3 | |||||||||||||
balance-sheet.row.total-non-current-assets | 0 | 3414.6 | 3532.3 | 3472.8 | |||||||||||||
balance-sheet.row.other-assets | 0 | 0 | 0 | 0 | |||||||||||||
balance-sheet.row.total-assets | 0 | 6073.8 | 6569.1 | 6551.3 | |||||||||||||
balance-sheet.row.account-payables | 0 | 179.1 | 205.4 | 155.6 | |||||||||||||
balance-sheet.row.short-term-debt | 0 | 1009.7 | 980.4 | 422.6 | |||||||||||||
balance-sheet.row.tax-payables | 0 | 1 | 1 | 0.7 | |||||||||||||
balance-sheet.row.long-term-debt-total | 0 | 1074.5 | 1622.5 | 2330.7 | |||||||||||||
Deferred Revenue Non Current | 0 | 102.9 | 118.5 | 127.2 | |||||||||||||
balance-sheet.row.deferred-tax-liabilities-non-current | 0 | - | - | - | |||||||||||||
balance-sheet.row.other-current-liab | 0 | 266.7 | 252.2 | 234.8 | |||||||||||||
balance-sheet.row.total-non-current-liabilities | 0 | 1074.7 | 1741 | 2480.6 | |||||||||||||
balance-sheet.row.other-liabilities | 0 | 0 | 0 | 0 | |||||||||||||
balance-sheet.row.capital-lease-obligations | 0 | 0.3 | 0.3 | 0.3 | |||||||||||||
balance-sheet.row.total-liab | 0 | 2535.3 | 3184.5 | 3300.2 | |||||||||||||
balance-sheet.row.preferred-stock | 0 | 0 | 0 | 0 | |||||||||||||
balance-sheet.row.common-stock | 0 | 393.2 | 407.5 | 407.4 | |||||||||||||
balance-sheet.row.retained-earnings | 0 | 958.9 | 931.5 | 819.4 | |||||||||||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | 0 | 60 | 26.1 | 27.3 | |||||||||||||
balance-sheet.row.other-total-stockholders-equity | 0 | 2020.3 | 2016.6 | 1994.5 | |||||||||||||
balance-sheet.row.total-stockholders-equity | 0 | 3432.5 | 3381.6 | 3248.6 | |||||||||||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 0 | 6073.8 | 6569.1 | 6551.3 | |||||||||||||
balance-sheet.row.minority-interest | 0 | 3 | 3.1 | 2.5 | |||||||||||||
balance-sheet.row.total-equity | 0 | 3435.5 | 3384.7 | 3251.1 | |||||||||||||
balance-sheet.row.total-liabilities-and-total-equity | 0 | - | - | - | |||||||||||||
Total Investments | 0 | 408.7 | 84.3 | 92.5 | |||||||||||||
balance-sheet.row.total-debt | 0 | 2084.4 | 2602.9 | 2753.3 | |||||||||||||
balance-sheet.row.net-debt | 0 | 1045.9 | 1276.7 | 1158.1 |
Pengestrømsopgørelse
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | 0 | 159.6 | 158.9 | 54.3 | |||||||||||||
cash-flows.row.depreciation-and-amortization | 0 | 268.9 | 275.4 | 257.5 | |||||||||||||
cash-flows.row.deferred-income-tax | 0 | 0 | -10.9 | -28 | |||||||||||||
cash-flows.row.stock-based-compensation | 0 | 0 | 10.9 | 28 | |||||||||||||
cash-flows.row.change-in-working-capital | 0 | -11.7 | -77.9 | -788.6 | |||||||||||||
cash-flows.row.account-receivables | 0 | 20.7 | -35.7 | 2.5 | |||||||||||||
cash-flows.row.inventory | 0 | -26.3 | -85.4 | -912.1 | |||||||||||||
cash-flows.row.account-payables | 0 | -6.1 | 43.2 | 121 | |||||||||||||
cash-flows.row.other-working-capital | 0 | 0 | 0 | 0 | |||||||||||||
cash-flows.row.other-non-cash-items | 0 | 107.8 | 137.3 | 63.1 | |||||||||||||
cash-flows.row.net-cash-provided-by-operating-activities | 0 | 0 | 0 | 0 | |||||||||||||
cash-flows.row.investments-in-property-plant-an-equipment | 0 | -107 | -245.9 | -286.5 | |||||||||||||
cash-flows.row.acquisitions-net | 0 | 0 | 3 | 0.4 | |||||||||||||
cash-flows.row.purchases-of-investments | 0 | -400 | -1310 | -510 | |||||||||||||
cash-flows.row.sales-maturities-of-investments | 0 | 450 | 1172.5 | 959.4 | |||||||||||||
cash-flows.row.other-investing-activites | 0 | 0 | 0 | 0.7 | |||||||||||||
cash-flows.row.net-cash-used-for-investing-activites | 0 | -57 | -380.4 | 164.1 | |||||||||||||
cash-flows.row.debt-repayment | 0 | -544.4 | -1520.6 | -680.8 | |||||||||||||
cash-flows.row.common-stock-issued | 0 | 0 | 0 | 0 | |||||||||||||
cash-flows.row.common-stock-repurchased | 0 | 0 | 0 | 0 | |||||||||||||
cash-flows.row.dividends-paid | 0 | -117.9 | -170.3 | -148.7 | |||||||||||||
cash-flows.row.other-financing-activites | 0 | -92.9 | 1323 | 1459.6 | |||||||||||||
cash-flows.row.net-cash-used-provided-by-financing-activities | 0 | -755.2 | -367.9 | 630.1 | |||||||||||||
cash-flows.row.effect-of-forex-changes-on-cash | 0 | 0 | 0 | 0 | |||||||||||||
cash-flows.row.net-change-in-cash | 0 | -287.7 | -254.6 | 380.6 | |||||||||||||
cash-flows.row.cash-at-end-of-period | 0 | 1038.5 | 1326.2 | 1580.8 | |||||||||||||
cash-flows.row.cash-at-beginning-of-period | 0 | 1326.2 | 1580.8 | 1200.2 | |||||||||||||
cash-flows.row.operating-cash-flow | 0 | 524.5 | 493.7 | -413.7 | |||||||||||||
cash-flows.row.capital-expenditure | 0 | -107 | -245.9 | -286.5 | |||||||||||||
cash-flows.row.free-cash-flow | 0 | 417.5 | 247.8 | -700.2 |
Resultatopgørelse række
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 0 | 1928.1 | 1970.3 | 1556.1 | |||||||||||||
income-statement-row.row.cost-of-revenue | 0 | 1500.6 | 1468.8 | 1268.2 | |||||||||||||
income-statement-row.row.gross-profit | 0 | 427.5 | 501.5 | 288 | |||||||||||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | |||||||||||||
income-statement-row.row.research-development | 0 | - | - | - | |||||||||||||
income-statement-row.row.selling-general-administrative | 0 | - | - | - | |||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | |||||||||||||
income-statement-row.row.other-expenses | 0 | 0.6 | 33.7 | 4.5 | |||||||||||||
income-statement-row.row.operating-expenses | 0 | 247.2 | 231 | 187.4 | |||||||||||||
income-statement-row.row.cost-and-expenses | 0 | 1747.7 | 1699.8 | 1455.6 | |||||||||||||
income-statement-row.row.interest-income | 0 | 31.6 | 31 | 53.6 | |||||||||||||
income-statement-row.row.interest-expense | 0 | 83.6 | 90.5 | 80.9 | |||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | |||||||||||||
income-statement-row.row.total-other-income-expensenet | 0 | -17.6 | -148.7 | -67.3 | |||||||||||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | |||||||||||||
income-statement-row.row.other-operating-expenses | 0 | 0.6 | 33.7 | 4.5 | |||||||||||||
income-statement-row.row.total-operating-expenses | 0 | -17.6 | -148.7 | -67.3 | |||||||||||||
income-statement-row.row.interest-expense | 0 | 83.6 | 90.5 | 80.9 | |||||||||||||
income-statement-row.row.depreciation-and-amortization | 0 | 268.9 | 275.4 | 257.5 | |||||||||||||
income-statement-row.row.ebitda-caps | 0 | - | - | - | |||||||||||||
income-statement-row.row.operating-income | 0 | 180.4 | 307.6 | 121.6 | |||||||||||||
income-statement-row.row.income-before-tax | 0 | 162.8 | 158.9 | 54.3 | |||||||||||||
income-statement-row.row.income-tax-expense | 0 | 3.2 | 0 | 66.7 | |||||||||||||
income-statement-row.row.net-income | 0 | 159.6 | 158.4 | -12.4 |
Ofte stillede spørgsmål
Hvad er Tianshui Zhongxing Bio-technology Co.,Ltd. (002772.SZ) samlede aktiver?
Tianshui Zhongxing Bio-technology Co.,Ltd. (002772.SZ) samlede aktiver er 6073765300.000.
Hvad er virksomhedens årlige omsætning?
Den årlige omsætning er N/A.
Hvad er virksomhedens profitmargin?
Virksomhedens profitmargin er 0.149.
Hvad er virksomhedens frie pengestrøm?
Det frie cash flow er 0.517.
Hvad er virksomhedens nettoprofitmargin?
Nettofortjenstmargenen er -0.002.
Hvad er firmaets samlede omsætning?
Den samlede omsætning er 0.001.
Hvad er Tianshui Zhongxing Bio-technology Co.,Ltd. (002772.SZ) nettoresultat (nettoindkomst)?
Nettoresultatet (nettoindkomsten) er 159581340.000.
Hvad er virksomhedens samlede gæld?
Den samlede gæld er 2084417918.000.
Hvad er tallet for driftsudgifter?
Driftsudgifterne er 247154405.000.
Hvad er firmaets likviditet?
Virksomhedens likviditet er 0.000.